989 related articles for article (PubMed ID: 25707349)
21. Is specimen radiography still necessary in patients with non-palpable breast cancer undergoing breast-conserving surgery using radioactive I-125 seed localization?
van Riet YE; Schipper RJ; van Merrienboer F; Orsini RG; Bloemen JG; Jansen FH; Nieuwenhuijzen GAP
Clin Imaging; 2021 Jan; 69():311-317. PubMed ID: 33045475
[TBL] [Abstract][Full Text] [Related]
22. Adequacy of invasive and in situ breast carcinoma margins in radioactive seed and wire-guided localization lumpectomies.
Law W; Cao X; Wright FC; Slodkowska E; Look Hong N; Curpen B
Breast J; 2021 Feb; 27(2):134-140. PubMed ID: 33270329
[TBL] [Abstract][Full Text] [Related]
23. A cosmesis outcome substudy in a prospective, randomized trial comparing radioguided seed localization with standard wire localization for nonpalpable, invasive, and in situ breast carcinomas.
Parvez E; Cornacchi SD; Hodgson N; Thoma A; Kong I; Foster G; Cheng J; Goldsmith CH; Dao D; Lovrics PJ
Am J Surg; 2014 Nov; 208(5):711-718. PubMed ID: 25201587
[TBL] [Abstract][Full Text] [Related]
24. Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins.
Agahozo MC; Berghuis SAM; van den Broek E; Koppert LB; Obdeijn IM; van Deurzen CHM
Ann Surg Oncol; 2020 Dec; 27(13):5296-5302. PubMed ID: 32578065
[TBL] [Abstract][Full Text] [Related]
25. Radioactive seed localization of nonpalpable breast lesions in an academic comprehensive cancer program community hospital setting.
Chiu JC; Ajmal S; Zhu X; Griffith E; Encarnacion T; Barr L
Am Surg; 2014 Jul; 80(7):675-9. PubMed ID: 24987899
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.
Postma EL; Verkooijen HM; van Esser S; Hobbelink MG; van der Schelling GP; Koelemij R; Witkamp AJ; Contant C; van Diest PJ; Willems SM; Borel Rinkes IH; van den Bosch MA; Mali WP; van Hillegersberg R;
Breast Cancer Res Treat; 2012 Nov; 136(2):469-78. PubMed ID: 23053639
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous use of an (125)I-seed to guide tumour excision and (99m)Tc-nanocolloid for sentinel node biopsy in non-palpable breast-conserving surgery.
Pouw B; van der Ploeg IM; Muller SH; Valdés Olmos RA; Janssen-Pinkse LK; Oldenburg HS; Vrancken Peeters MT
Eur J Surg Oncol; 2015 Jan; 41(1):71-8. PubMed ID: 25458078
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-Year follow-up from a randomized controlled trial.
Fung F; Cornacchi SD; Reedijk M; Hodgson N; Goldsmith CH; McCready D; Gohla G; Boylan C; Lovrics PJ
Am J Surg; 2017 Apr; 213(4):798-804. PubMed ID: 27810132
[TBL] [Abstract][Full Text] [Related]
29. Radioactive seed localization for non-palpable breast cancer.
Barentsz MW; van den Bosch MA; Veldhuis WB; van Diest PJ; Pijnappel RM; Witkamp AJ; Verkooijen HM
Br J Surg; 2013 Apr; 100(5):582-8. PubMed ID: 23456627
[TBL] [Abstract][Full Text] [Related]
30. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
Laws A; Brar MS; Bouchard-Fortier A; Leong B; Quan ML
J Surg Oncol; 2018 Dec; 118(7):1205-1211. PubMed ID: 30293241
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting surgical margins in nonpalpable breast tumors excised with the radioguided occult lesion localization approach.
Vernet-Tomas Mdel M; Ortega M; Vidal S; Corominas JM; Carreras R
J Obstet Gynaecol Res; 2011 May; 37(5):422-7. PubMed ID: 21272155
[TBL] [Abstract][Full Text] [Related]
32. Radioactive seed localization is the preferred technique in nonpalpable breast cancer compared with wire-guided localization and radioguided occult lesion localization.
Theunissen CI; Rust EA; Edens MA; Bandel C; Van't Ooster-van den Berg JG; Jager PL; Noorda EM; Francken AB
Nucl Med Commun; 2017 May; 38(5):396-401. PubMed ID: 28362718
[TBL] [Abstract][Full Text] [Related]
33. Adoption and outcomes of radioguided seed localization for non-palpable invasive and in-situ breast cancer at three academic tertiary care centers.
Parvez E; Cornacchi SD; Fu E; Hodgson N; Farrokhyar F; Reid S; Lovrics PJ
Am J Surg; 2018 Dec; 216(6):1160-1165. PubMed ID: 30005808
[TBL] [Abstract][Full Text] [Related]
34. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
35. Radioguided occult lesion localisation (ROLL) in breast-conserving surgery after neoadjuvant chemotherapy.
Donker M; Straver ME; Rutgers EJ; Valdés Olmos RA; Loo CE; Sonke GS; Wesseling J; Vrancken Peeters MJ
Eur J Surg Oncol; 2012 Dec; 38(12):1218-24. PubMed ID: 22871497
[TBL] [Abstract][Full Text] [Related]
36. The effect of introducing an in-theatre intra-operative specimen radiography (IOSR) system on the management of palpable breast cancer within a single unit.
Layfield DM; May DJ; Cutress RI; Richardson C; Agrawal A; Wise M; Yiangou C
Breast; 2012 Aug; 21(4):459-63. PubMed ID: 22119488
[TBL] [Abstract][Full Text] [Related]
37. What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?
Ouldamer L; Lechaux E; Arbion F; Body G; Vildé A
Breast; 2014 Dec; 23(6):889-93. PubMed ID: 25456102
[TBL] [Abstract][Full Text] [Related]
38. Localization of non-palpable breast cancer using a radiolabelled titanium seed.
van Riet YE; Jansen FH; van Beek M; van de Velde CJ; Rutten HJ; Nieuwenhuijzen GA
Br J Surg; 2010 Aug; 97(8):1240-5. PubMed ID: 20602505
[TBL] [Abstract][Full Text] [Related]
39. Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial.
Langhans L; Tvedskov TF; Klausen TL; Jensen MB; Talman ML; Vejborg I; Benian C; Roslind A; Hermansen J; Oturai PS; Bentzon N; Kroman N
Ann Surg; 2017 Jul; 266(1):29-35. PubMed ID: 28257326
[TBL] [Abstract][Full Text] [Related]
40. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
